Published in Pathol Res Pract on June 20, 2008
Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med (2010) 7.31
The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury. PLoS One (2013) 2.14
Mitochondria and tumor progression in ulcerative colitis. J Natl Cancer Inst (2013) 2.09
Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev (2014) 1.57
ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis. EMBO J (2009) 1.46
Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol (2011) 1.35
The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci (2013) 1.30
Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2010) 1.26
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. PLoS One (2010) 1.25
Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res (2011) 1.23
The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron (2010) 1.23
The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol (2011) 1.22
Colitis-associated cancer: the role of T cells in tumor development. Semin Immunopathol (2009) 1.19
Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis. World J Gastroenterol (2010) 0.99
Gut microbiota imbalance and colorectal cancer. World J Gastroenterol (2016) 0.99
Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice. J Inflamm (Lond) (2010) 0.93
Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation. PLoS One (2011) 0.91
Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer. World J Gastroenterol (2014) 0.91
Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection. J Biol Chem (2011) 0.89
Soybean and fish oil mixture increases IL-10, protects against DNA damage and decreases colonic inflammation in rats with dextran sulfate sodium (DSS) colitis. Lipids Health Dis (2010) 0.89
Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. Int J Mol Sci (2015) 0.88
TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2011) 0.87
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work? Redox Biol (2015) 0.87
Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage. J Clin Invest (2015) 0.87
Chronic inflammation-related DNA damage response: a driving force of gastric cardia carcinogenesis. Oncotarget (2015) 0.86
Reduced hTERT protein levels are associated with DNA aneuploidy in the colonic mucosa of patients suffering from longstanding ulcerative colitis. Int J Mol Med (2014) 0.84
DNA methylation in inflammatory bowel disease and beyond. World J Gastroenterol (2013) 0.84
How do cytokines trigger genomic instability? J Biomed Biotechnol (2012) 0.82
Pseudolaric acid B inhibits inducible cyclooxygenase-2 expression via downregulation of the NF-κB pathway in HT-29 cells. J Cancer Res Clin Oncol (2012) 0.81
Lemon verbena infusion consumption attenuates oxidative stress in dextran sulfate sodium-induced colitis in the rat. Dig Dis Sci (2011) 0.81
Telomere length in non-neoplastic colonic mucosa in ulcerative colitis (UC) and its relationship to the severe clinical phenotypes. Clin Exp Med (2014) 0.81
A Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in mice. Mediators Inflamm (2012) 0.81
Effects of combined radiofrequency radiation exposure on levels of reactive oxygen species in neuronal cells. J Radiat Res (2013) 0.81
Dietary modulation of inflammation-induced colorectal cancer through PPARγ. PPAR Res (2009) 0.80
Telomere shortening correlates to dysplasia but not to DNA aneuploidy in longstanding ulcerative colitis. BMC Gastroenterol (2014) 0.80
Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities. Int J Mol Sci (2016) 0.80
Recent advancement in understanding colitis-associated tumorigenesis. Inflamm Bowel Dis (2014) 0.79
Reactive oxygen species induce Cox-2 expression via TAK1 activation in synovial fibroblast cells. FEBS Open Bio (2015) 0.79
p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia. World J Gastroenterol (2011) 0.79
Comparative proteomic analysis of cysteine oxidation in colorectal cancer patients. Mol Cells (2013) 0.78
Propionate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Reducing Inflammation and Oxidative Stress. Front Pharmacol (2016) 0.78
Non-apoptotic function of caspases in a cellular model of hydrogen peroxide-associated colitis. J Cell Mol Med (2013) 0.77
Aberrant methylation of PSD disturbs Rac1-mediated immune responses governing neutrophil chemotaxis and apoptosis in ulcerative colitis-associated carcinogenesis. Int J Oncol (2011) 0.77
Lipopolysaccharide (LPS) of helicobacter modulates cellular DNA repair systems in intestinal cells. Clin Exp Med (2010) 0.77
Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.76
Selenoproteins and oxidative stress-induced inflammatory tumorigenesis in the gut. Cell Mol Life Sci (2016) 0.76
The effect of L-ascorbic acid and/or tocopherol supplementation on electrophysiological parameters of the colon of rats chronically exposed to lead. Med Sci Monit (2011) 0.76
Risk modification of colorectal cancer susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol (2012) 0.76
TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis. Int J Mol Med (2014) 0.76
Repeated H2 O2 exposure drives cell cycle progression in an in vitro model of ulcerative colitis. J Cell Mol Med (2013) 0.76
Oral nanotherapeutics: effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced colitis. J Gastroenterol (2013) 0.75
Managing ulcerative colitis by increasing hydrogen production via oral administration of Acarbose. Afr J Tradit Complement Altern Med (2013) 0.75
Acarbose: a new option in the treatment of ulcerative colitis by increasing hydrogen production. Afr J Tradit Complement Altern Med (2012) 0.75
Selenoprotein P in colitis-associated carcinoma. Mol Cell Oncol (2015) 0.75
Campomanesia adamantium Peel Extract in Antidiarrheal Activity: The Ability of Inhibition of Heat-Stable Enterotoxin by Polyphenols. PLoS One (2016) 0.75
Biomarkers for colitis-associated colorectal cancer. World J Gastroenterol (2016) 0.75
Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice. Oncotarget (2016) 0.75
[Colorectal polyposis syndrome: a guide to diagnosis]. Pathologe (2011) 0.75
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
The coccoid forms of Helicobacter pylori. Criteria for their viability. Epidemiol Infect (1993) 2.61
A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut (1997) 2.32
Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn. Aliment Pharmacol Ther (2013) 2.13
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori. Aliment Pharmacol Ther (2014) 2.11
Characterization of yellow plaques found in the small bowel during double-balloon enteroscopy. Endoscopy (2007) 2.06
Diagnostic and therapeutic impact of double-balloon enteroscopy. Endoscopy (2006) 2.03
[The diagnostic value of the amino acid absorption test in detection of a disorder of exocrine pancreatic function]. Z Gastroenterol (1992) 2.02
Analysis of nerves in chronic pancreatitis. Gastroenterology (1988) 2.01
[Short guideline for the management of dyspepsia]. Dtsch Med Wochenschr (2004) 2.01
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis (2011) 1.80
Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease. Scand J Gastroenterol Suppl (1988) 1.77
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
A retrospective analysis of emergency double-balloon enteroscopy for small-bowel bleeding. Endoscopy (2009) 1.72
Incidence of bleeding lesions within reach of conventional upper and lower endoscopes in patients undergoing double-balloon enteroscopy for obscure gastrointestinal bleeding. Aliment Pharmacol Ther (2008) 1.70
The role of infection in acute pancreatitis. Gut (1999) 1.66
Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori. Gastroenterology (1993) 1.66
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori. Helicobacter (1998) 1.61
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.56
Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. Z Gastroenterol (2003) 1.52
13C-urea breath test for the diagnosis of Helicobacter pylori infection. A further simplification for clinical practice. Scand J Gastroenterol (1998) 1.48
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47
Interdigestive cycling in chronic pancreatitis: altered coordination among pancreatic secretion, motility, and hormones. Gastroenterology (1995) 1.47
The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer (2000) 1.46
Biliary strictures are not the cause of pain in patients with chronic pancreatitis. Pancreas (2004) 1.44
Decision-making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol (1999) 1.43
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40
[Order in the chaos of classifications of erosions of the gastric mucosa]. Leber Magen Darm (1993) 1.39
Coccoid like forms (CLF) of Helicobacter pylori. Enzyme activity and antigenicity. Zentralbl Bakteriol (1993) 1.38
Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study. Ital J Gastroenterol Hepatol (1998) 1.38
[Polymorphism in Helicobacter pylori--a key function in recurrence of infection?]. Med Klin (Munich) (1992) 1.37
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol (2001) 1.35
Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut (1986) 1.32
Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology (1992) 1.31
Ultrastructural localisation of urease in outer membrane and periplasm of Campylobacter pylori. J Clin Pathol (1989) 1.29
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology (1999) 1.27
Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol (1995) 1.27
Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol (1992) 1.26
A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut (1999) 1.26
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut (2004) 1.22
Role of phospholipase A2 in human acute pancreatitis. Gastroenterology (1989) 1.20
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int J Cancer (1997) 1.18
ERCP using single-balloon instead of double-balloon enteroscopy in patients with Roux-en-Y anastomosis. Endoscopy (2008) 1.18
Helicobacter pylori infection: a clinical overview. Dig Liver Dis (2008) 1.17
Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J Clin Microbiol (2006) 1.17
The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol (1998) 1.16
Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1. Br J Cancer (2002) 1.16
Diagnosis of Helicobacter pylori infection by HpSA test. European Helicobacter pylori HpSA Study Group. Lancet (1999) 1.16
Review article: helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther (2004) 1.16
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer (1998) 1.15
A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther (2001) 1.14
PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas (1991) 1.14
Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations. Br J Cancer (2013) 1.14
Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction. Am J Gastroenterol (1994) 1.14
Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut (1998) 1.14
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut (1997) 1.13
Changes in peptidergic innervation in chronic pancreatitis. Pancreas (1992) 1.12
Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations. Mod Pathol (2000) 1.11
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther (2002) 1.10
Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice. Br J Cancer (2013) 1.10
Duodenum-preserving pancreatic head resection: Long-term results. J Gastrointest Surg (2006) 1.10
Treatment of Helicobacter pylori. Best Pract Res Clin Gastroenterol (2007) 1.10
Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol (1998) 1.08
The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut (1998) 1.08
Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Gut (2005) 1.08
Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature. Pathol Res Pract (2001) 1.07
Identification of structures containing polyphosphate in Helicobacter pylori. J Gen Microbiol (1993) 1.06
Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol (1996) 1.05
Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors. Am J Gastroenterol (1993) 1.03
Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis. Dig Dis Sci (1998) 1.02
Chromoendoscopy: from a research tool to clinical progress. Dig Dis (2002) 1.02
A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs (1999) 1.02
Ultrastructural localization of urease of Helicobacter pylori. Med Microbiol Immunol (1993) 1.02
Double-balloon enteroscopy-assisted virtual chromoendoscopy for small-bowel disorders: a case series. Endoscopy (2009) 1.02
Invasion of campylobacter-like organisms in the duodenal mucosa in patients with active duodenal ulcer. Klin Wochenschr (1987) 1.02
Expression of carbonic anhydrase IX in human pancreatic cancer. Aliment Pharmacol Ther (2003) 1.01
alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives. Gut (2000) 1.01
Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer (2002) 1.00
Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis (1998) 1.00
A metastatic endocrine-neurogenic tumor of the ampulla of Vater with multiple endocrine immunoreaction--malignant paraganglioma? Digestion (1985) 1.00
Recommendations of the ESGE workshop on Ethics in Teaching and Learning Endoscopy. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003. Endoscopy (2003) 1.00
Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia. Am J Gastroenterol (1997) 1.00
In vitro inhibition of Helicobacter pylori urease: biochemical and ultrastructural analysis. Eur J Clin Invest (1991) 0.99
Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. Am J Gastroenterol (1999) 0.99
Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors. Pathol Res Pract (1998) 0.99
CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis. Am J Gastroenterol (1998) 0.98
Inflammation and Barrett's carcinogenesis. Pathol Res Pract (2012) 0.98
Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int J Pancreatol (1986) 0.98